← Open Payments lookup

ELIAS RUILOBA: Open Payments

NPI 1124014196 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,586 in 180 payments from 17 companies in 2025. Trend: 2023 $3,179 · 2024 $2,909 · 2025 $3,586

Food & beverage: $3,586
CompanyPaymentsAmount
ABBVIE INC.60$971
Lundbeck LLC18$439
Otsuka America Pharmaceutical, Inc.17$423
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$354
Vanda Pharmaceuticals Inc.10$186
Collegium Pharmaceutical, Inc.10$163
Axsome Therapeutics, Inc.8$153
Biogen, Inc.7$142
Takeda Pharmaceuticals U.S.A., Inc.9$141
E.R. Squibb & Sons, L.L.C.2$131

Products named: VRAYLAR, REXULTI, CAPLYTA, Jornay PM, Auvelity, FANAPT, ZURZUVAE, TRINTELLIX.

Industry payments across AZ — which companies pay providers there.